NCT04194905View on ClinicalTrials.gov

Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 21, 2020

Primary Completion Date

November 21, 2020

Study Completion Date

December 15, 2020

Conditions
Bioequivalence
Interventions
DRUG

Levonorgestrel 0.1 mg and Ethinyl estradiol 0.02 mg Test Product

Coated Tablets

DRUG

Levonorgestrel 0.1 mg and Ethinyl estradiol 0.02 mg Reference Product

Coated Tablets

Trial Locations (1)

7510491

Innolab, Santiago

Sponsors
All Listed Sponsors
lead

Laboratorios Andromaco S.A.

INDUSTRY

NCT04194905 - Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product | Biotech Hunter | Biotech Hunter